SCHEMBL21082399

SCHEMBL21082399

CC1C(O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1n1cnc2c(N)ncnc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 4/20 0.82
▸ P2RX3 P56373 4/20 0.82
▸ P2RX2 Q9UBL9 2/20 0.82
▸ P2RY1 P47900 7/20 0.79
▸ P2RY2 P41231 3/20 0.79
▸ P2RX4 Q99571 2/20 0.79
▸ SRC P12931 2/20 0.79
▸ SMN1; SMN2 Q16637 2/20 0.79
▸ ALDH1A1 P00352 2/20 0.79
▸ RNASEL Q05823 3/20 0.75
▸ TRPM2 O94759 2/20 0.74
▸ MACROD2 A1Z1Q3 1/20 0.74
▸ SIRT6 Q8N6T7 1/20 0.74
▸ MACROD1 Q9BQ69 1/20 0.74
▸ DNPH1 O43598 1/20 0.70
▸ PRKAB2 O43741 1/20 0.70
▸ LDHA P00338 1/20 0.70
▸ ADRB2 P07550 1/20 0.70
▸ FBP1 P09467 1/20 0.70
▸ ADORA1 P30542 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20820215 1.00 P2RX1 (0.82) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL24063413 1.00 P2RX1 (0.82) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL29642908 1.00 P2RX1 (0.82) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL16203363 1.00 P2RX1 (0.82) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL12884728 0.94 P2RY1 (0.81) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL12932315 0.94 P2RY1 (0.81) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL1062593 0.94 P2RY1 (0.81) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL19888462 0.93 TRPM2 (0.86) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL12932265 0.93 P2RX3 (0.75) P2RX1P2RX3P2RX2P2RY1P2RY2
Adenosine Triphosphate SCHEMBL20550531 0.92 P2RY1 (0.94) P2RX1P2RX3P2RX2P2RY1P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4015005-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF ModernaTX, Inc. (US) 2022-06-22 — — EP disclosed
EP-3682905-B1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF MODERNATX INC (US) 2021-12-01 — — EP disclosed
EP-3682905-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF ModernaTX, Inc. (US) 2020-07-22 — — EP disclosed
EP-3492109-B1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF MODERNATX INC (US) 2020-03-04 — — EP disclosed
EP-3492109-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF Moderna Therapeutics, Inc. (US) 2019-06-05 — — EP disclosed
Send feedback